Pfizer CEO: Metsera deal gives us ‘one of the most exciting, advanced portfolios’ in obesity drugsNovember 10, 2025
Share Facebook Twitter LinkedIn Pinterest Email CNBC’s Steve Liesman joins ‘Squawk Box’ to break down the latest results from the CNBC/NRF Retail Monitor.